The strategic move is aimed at integrating automated, high-throughput gene synthesis into Regeneron's in-house laboratories.

To help address the impact of COPD on patients and communities, global healthcare companies Sanofi and Regeneron are working together to study the ripple effects of COPD and to help create a ...

His research gives me great hope for the future of global health and scientific innovation." Now in its landmark 75 th year, Regeneron ISEF remains the premier global stage for the next generation of ...

Now in its landmark 75 th year, Regeneron ISEF remains the premier global stage for the next generation of scientists and engineers. This milestone year celebrates decades of scientific discovery ...

Yancopoulos Innovator Award at the 75 th Regeneron International Science and Engineering Fair (Regeneron ISEF), the world's largest pre-college science and engineering competition. The award is named ...

In a high-profile antitrust case, a federal jury in Delaware awarded Regeneron Pharmaceuticals over $405 million in damages, finding that Amgen Inc. illegally stifled competition and disrupted ...

Throughout the last three months, 16 analysts have evaluated Regeneron Pharmaceuticals (NASDAQ:REGN), offering a diverse set of opinions from bullish to bearish. The following table summarizes ...

The latest price target for Regeneron Pharmaceuticals (NASDAQ:REGN) was reported by Citigroup on May 14, 2025. The analyst firm set a price target for $700.00 expecting REGN to rise to within 12 ...

A talented learner from Luhlaza High School in Khayelitsha, Salusiwe Mxayiya is gearing up to represent her country at the esteemed Regeneron International Science and Engineering Fair (ISEF), also ...

We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other worst ...